GlaxoSmithKline S.A.E. (BIOC) Key Statistics
19 reported figures for GlaxoSmithKline S.A.E. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 25.47B
- Dividend yield
- 0.33%
Income (latest fiscal year)
- Revenue
- EGP 1.62B
- Net income
- EGP 34.03M
- EBITDA
- EGP 139.12M
- Free cash flow
- EGP 182.31M
Balance sheet
- Total assets
- EGP 2.04B
- Total debt
- EGP 0
Growth
- Revenue growth
- 11.69%
- Profit growth
- -66.75%
- EPS growth
- -66.75%
Per share
- EPS (fiscal year)
- 0.41
- Dividend per share
- 0.5
Technical
- RSI (14)
- 39.9
- 50-day moving average
- EGP 282.64
- 200-day moving average
- EGP 119.64
- Beta (1Y)
- 0.22
Shares
- Shares outstanding
- 83.51M
- Free float
- 2.91%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.